Evan Adler, DPM
Foot & Ankle Surgery · Old Bridge, NJNPI 1740425644
Payments from drug & device makers
Across 440 payments — averaging $443.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$188K
- Stryker$4K
- Organogenesis Inc.$806
- Smith+Nephew$616
- Integra Lifesciences Corporation$363
- Johnson & Johnson$275
- plus $2K from 26 others
Across 1 payment — averaging $3900.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Musculoskeletal Transplant Foundation Inc.$4K
What the payments were for
- Consulting fees$166,32785%
- Travel & lodging$17,7559%
- Food & beverage$10,8826%
- Entertainment$1360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 214 | $187,801 |
| Stryker(2 entities) | 62 | $3,737 |
| Organogenesis Inc. | 38 | $806 |
| Smith+Nephew | 43 | $616 |
| Integra Lifesciences Corporation | 5 | $363 |
| Johnson & Johnson | 7 | $275 |
| Paratek Pharmaceuticals, Inc. | 16 | $239 |
| AbbVie | 3 | $159 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 9 | $137 |
| Abbott | 1 | $127 |
| Amgen | 7 | $106 |
| Convatec Inc. | 6 | $105 |
| Sanara Medtech Inc. | 4 | $78 |
| Acera Surgical, Inc. | 2 | $65 |
| Zimmer Biomet | 2 | $53 |
| Treace Medical Concepts, Inc. | 2 | $49 |
| Bioventus LLC | 2 | $44 |
| Seapearl East, Inc | 1 | $41 |
| Melinta Therapeutics, LLC | 3 | $40 |
| Aroa Biosurgery Incorporated | 1 | $32 |
| Kerecis Limited | 1 | $31 |
| Avita Medical Americas, LLC | 1 | $27 |
| Medshape, Inc. | 1 | $23 |
| Polarityte, Inc. | 1 | $21 |
| Polynovo North America LLC | 1 | $19 |
| Dynasplint Systems Inc. | 1 | $18 |
| Medtronic | 1 | $18 |
| Paragon 28, Inc. | 1 | $16 |
| Solventum Corporation | 1 | $14 |
| Advanced Oxygen Therapy Inc. | 1 | $14 |
| Merck | 1 | $13 |
| Cardiovascular Systems Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$936
- PROPHECY$770
- INTEGRA DERMAL REGENERATION TEMPLATE$312
- PRIMATRIX$312
- AUGMENT INJECTABLE$307
- VARIAX$306
- INFINITY$205
- SUPERA$127
- BME NITINOL CONTINUOUS COMPRESSION IMPLANTS$125
- DALVANCE$123
How this compares
$195,100 in reported general payments places this provider in the 95th percentile of 542 foot & ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 16 | $44,252 |
| JubliaEfinaconazole | 13 | $9,464 |
| Gabapentin | 15 | $279 |
| Doxycycline Hyclate | 18 | $143 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $87 |
| Methylprednisolone | 17 | $83 |
| Triamcinolone Acetonide | 12 | $50 |
| Meloxicam | 17 | $15 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $616 | $44,25216 claims |
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $137 | $9,46413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 542 foot & ankle surgery providers in New Jersey.
Other foot & ankle surgery in Old Bridge
- Wayne BerberianNewark$2M
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$847K
- Shane HollawellManasquan$753K
- Michael SubikLyndhurst$529K
- Krupa PatelMorris Plains$281K
- Johanna GodoyWayne$254K
- Andrew BriefRidgewood$253K
- Sheldon LinNewark$253K
- Mark SolomonCedar Knolls$232K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.